Jack Kramarczyk

Jack Kramarczyk is an accomplished professional in the biotechnology sector with extensive experience in process development and engineering. Currently serving as Director at Moderna Therapeutics since July 2017, Kramarczyk leads a team focused on the encapsulation of mRNA into lipid nanoparticles and the associated downstream processing. Previously, at Axcella Health, Kramarczyk founded a laboratory and developed purification processes while managing a team of engineers. Kramarczyk has also worked as a Senior Process Engineer at Virdante Pharmaceuticals and Wyeth Biotech, where responsibilities included developing and supporting purification processes for therapeutic proteins. Kramarczyk holds a Master of Science in Chemical & Biotechnology Engineering and a Bachelor of Science in Chemical Engineering from Tufts University.